KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Acquisitions & Divestments (2016 - 2023)

Amgen has reported Change in Acquisitions & Divestments over the past 15 years, most recently at -$575.0 million for Q3 2023.

  • Quarterly results put Change in Acquisitions & Divestments at -$575.0 million for Q3 2023, changed N/A from a year ago — trailing twelve months through Jun 2024 was -$575.0 million (down 125.61% YoY), and the annual figure for FY2023 was $550.0 million, down 50.89%.
  • Change in Acquisitions & Divestments for Q3 2023 was -$575.0 million at Amgen, down from $1.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for AMGN hit a ceiling of $10.5 billion in Q1 2019 and a floor of -$9.6 billion in Q4 2019.
  • Median Change in Acquisitions & Divestments over the past 5 years was $1.1 billion (2022), compared with a mean of $1.3 billion.
  • Biggest five-year swings in Change in Acquisitions & Divestments: plummeted 173.88% in 2020 and later skyrocketed 3412.5% in 2023.
  • Amgen's Change in Acquisitions & Divestments stood at -$9.6 billion in 2019, then surged by 118.59% to $1.8 billion in 2020, then surged by 148.21% to $4.4 billion in 2021, then plummeted by 74.71% to $1.1 billion in 2022, then plummeted by 151.34% to -$575.0 million in 2023.
  • The last three reported values for Change in Acquisitions & Divestments were -$575.0 million (Q3 2023), $1.0 million (Q2 2023), and $1.1 billion (Q1 2023) per Business Quant data.